ESMO/X
May 24, 2025, 20:22
ESMO-Magnitude of Clinical Benefit Scale version 2.0
European Society for Medical Oncology (ESMO) posted on X:
“ESMO-MCBS v2.0 is now out. Significant enhancements in cancer therapies evaluation:
robust
understanding of score’s meaning,
accuracy, fairness, utility of treatment assessments,
advances in science, clinical practice, patient input.
Released on the wave of Clinical Trials Day, ESMO-MCBS v 2.0 reinforces the role of research in improving Cancer Care.”
Title: ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)
Authors: N.I. Cherny, S.F. Oosting, U. Dafni, N.J. Latino, M. Galotti, P. Zygoura, G. Dimopoulou, T. Amaral, J. Barriuso, A. Calles, B. Kiesewetter, C. Gomez-Roca, B. Gyawali, M. Piccart, A. Passaro, F. Roitberg, N. Tarazona, D. Trapani, G. Curigliano, R. Wester, G. Zarkavelis, C. Zielinski, E.G.E. de Vries.
You can read the Full Article in Annals of Oncology.
More posts featuring ESMO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 24, 2025, 20:22
May 24, 2025, 20:10